David Moreira Appointed Vice President of Marketing, Menicon America

NAGOYA, Japan, July 20, 2010 – -Menicon focusing on expanding its presence in the custom contact lens
market-

Menicon Co., Ltd. announced on July 20 the appointment of David Moreira
as Vice President of Marketing for Menicon America Inc. Moreira will report
to Jonathan Jacobson, President of Menicon America.
Moreira joins [...]

World’s Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients

ZURICH, July 19, 2010 – Today, Novo Nordisk announced the landmark recruitment of the 60,000th
patient in the A1chieve(R) study – an observational study designed to
investigate the effects of modern insulins in the management of type 2
diabetes.[1]

Spanning 28 countries across 4 continents and involving more than 3300
physicians, A1chieve(R) is set to [...]

Visage Imaging Releases Amira 5.3

Introducing a new powerful toolset for Neuroscience and a multitude of new features and improvements

SAN DIEGO, California, July 19, 2010 – Visage Imaging(R), Inc., a wholly owned subsidiary of Pro Medicus Ltd.
(ASX: PME), is pleased to announce the immediate release of Amira 5.3, a new
major version of its market-leading software platform for visualizing,
analyzing, and [...]

Abbott’s PROGRESS Study of Kaletra and Isentress Compared with a Standard HIV Regimen Meets the Pre-Specified Primary Efficacy Endpoint

PROGRESS is the First Study to Present 48-Week Efficacy Results for this Combination When Used in Treatment-Naive Patients with HIV

VIENNA, July 19, 2010 – Abbott (NYSE: ABT) today presented 48-week findings comparing an HIV
regimen of its protease inhibitor (PI), Kaletra(R) (lopinavir/ritonavir), and
Merck's integrase inhibitor, Isentress(R) (raltegravir), to a traditional HIV
regimen of Kaletra and the [...]

Bill Gates: World Has Historic Opportunity to ‘Change the Face of AIDS’

In Keynote Speech to AIDS Conference, Gates Outlines Roadmap to Reduce Annual New HIV Infections 90% by 2031

VIENNA, July 19, 2010 – Speaking to the 18th International AIDS Conference today, Bill Gates
called on all countries to keep up the fight against HIV/AIDS, saying the
world has an historic opportunity to "change the face of AIDS." [...]

Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance

Terms include initial US$1.25 million ELITech equity investment in Corgenix with options for US$3 million total, plus distribution agreement and diagnostic system co-development

DENVER and PARIS, July 19, 2010 – Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide
developer and marketer of diagnostic test kits, and the ELITech Group, a
Paris, France-based, privately held group of [...]

Amira Pharmaceuticals Hits Two Development Milestones Related to FLAP Inhibitor Program

SAN DIEGO, July 19, 2010 – "Amira Pharmaceuticals, Inc. announced today that its FLAP
(5-lipoxygenase-activating protein) program, which is partnered with
GlaxoSmithKline, has achieved two clinical development milestones."

These milestones are related to the successful progression of the program
to Phase 2 studies, which explore the use of the Amira discovered FLAP
inhibitor in patients [...]

International Organizations Agree to Take Concerted Action to End Pediatric HIV/AIDS

"No child should enter this world infected with HIV."
VIENNA, July 19, 2010 – A global alliance of international organizations, including the heads of
UNICEF, UNAIDS and The Global Fund to Fight AIDS, Tuberculosis and Malaria as
well as other NGOs including the Pan African Treatment Access Movement,
Health GAP, Ugandan Pediatric Association and the Global AIDS Alliance [...]

ThromboGenics Announces Publication of Positive Microplasmin Phase II Data in the Journal Retina

Paper Highlights the Potential of Microplasmin for Nonsurgical Treatment of Vitreomacular Adhesion

LEUVEN, Belgium, July 15, 2010 – ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical
company focused on the discovery and development of innovative treatments for
eye disease, vascular disease and cancer, announces today that positive
microplasmin Phase II trial results, evaluating the product for the
nonsurgical treatment of [...]

Oasmia Pharmaceutical AB, Sweden – Listing Prospectus: NASDAQ OMX Stockholm

A Number of Promising New Product Candidates for Cancer Treatment, Within Both Human and Veterinary Oncology

UPPSALA, Sweden, July 15, 2010 – ABOUT OASMIA
Oasmia is developing a new generation of drugs with emphasis
on human and veterinary oncology. Our main business activity focuses on
improving product life cycles and the versatility of current [...]

New Psoriasis eCommerce Shop Launched by PAPAA

ST ALBANS, England, July 15, 2010 – The Psoriasis and Psoriatic Arthritis Alliance (PAPAA) has launched a new
secure eCommerce site www.psoriasis-shop.org . Visitors can now order
free information, pay and renew their subscription, make donations and buy
from a selection of publications aimed at providing practical information on
these conditions.

A spokesperson for the [...]

Varicent to Provide Global Eye Care Leader Alcon With Global Solution for Sales Performance Management

Varicent expected to enhance sales performance management functionality for multiple geographic business units

TORONTO, July 15, 2010 – Varicent Software Incorporated, the leading innovator in incentive
compensation (ICM) and sales performance management (SPM) solutions,
announced today that it will provide its innovative solutions to Alcon, the
world's largest eye-care company.
Alcon Japan recently chose Varicent [...]

Frost & Sullivan Recognizes Camozzi spa for Outstanding Customer Service in the Western European Pneumatic Valves Market

LONDON, July 15, 2010 – Based on its recent research on the pneumatic valves market, Frost &
Sullivan presents Camozzi spa with the "2010 Western European Customer
Service Leadership Award." The mature and consolidated pneumatic valves
market in Western Europe requires manufacturers to excel in the area of
customer service for gaining a competitive edge. Camozzi spa has [...]

Second Quarter 2010 Results Date Notification – August 4, 2010

DUBLIN, July 15, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, will announce second quarter 2010 earnings on
Wednesday August 4, 2010.

Results press release will be issued at: 12:00 BST / 07:00 EDT
Investor conference call time: [...]

JuvoLab Announces Results of Study Analyzing Entire Global Oncology Community’s Twitter Usage at ASCO 2010

First-ever aggregate analysis of physician, pharmaceutical and biotechnology industry, academic association, institution, journal, marketing and communications industry, non-profit organization, and patient advocate social media usage to discuss and disseminate breaking data and conduct compliant corporate promotion at the 2010 American Society of Clinical Oncology Annual Meeting (ASCO) released today

NEW YORK, July 15, 2010 – [...]

Agendia to Provide Testimony at Public Meeting on FDA Oversight of Laboratory-Developed Tests

World Leader in Cancer Diagnostics Joins Nation's Top Safety Agency in Calling for Risk-Based Oversight of Genomic Testing

IRVINE, California, and AMSTERDAM, July 15, 2010 – Agendia, a world leader in molecular cancer diagnostics, announced today
that company CEO Dr. Bernhard Sixt will provide testimony at a public meeting
on July 20 in Washington D.C. on the [...]

NEXUS Biosystems Acquires Tecan Group’s REMP Sample Management Business

POWAY, California, July 15, 2010 – NEXUS Biosystems, Inc., a leading innovator and worldwide provider of
automated sample management systems, today announced the signing of an
agreement to acquire REMP AG, a wholly-owned subsidiary of Tecan, as well as
other related assets. Under this agreement, NEXUS will acquire all activities
of Tecan's REMP(R) Sample Management business segment from [...]

Substantial Revenues and Earnings Plus for Gerresheimer

D??SSELDORF, Germany, July 14, 2010 -

– Group Revenues in the Second Quarter up by 6.8% (Excluding
Technical Plastic Systems)

– Further Solid Growth of the Pharma Business – Improvement in
the Cosmetics and Life Science Research Segments

[...]

New Procedures Consult Mobile From Elsevier Enables Clinicians to View Top Medical Procedures From Mobile Devices

Physicians, Residents and Students now Able to Prepare, Review and Test Knowledge of Common Medical Procedures Anywhere, Anytime

PHILADELPHIA, Pennsylvania, July 14, 2010 – Elsevier, the world's leading publisher of scientific, technical, and
medical information products and services, announced today that physicians,
residents and students will be able to visualize and review over 300 top
medical procedures on [...]

Increased Need for Remote Patient Monitoring Drives the Data Management Systems for Patient Monitoring Markets in Europe, Finds Frost & Sullivan

LONDON, July 14, 2010 – The increased need for real-time data management and the improved
receptiveness of a technology to monitor patients effectively are driving the
markets for data management systems (DMS) for patient monitoring in Europe.
The participants are looking for options that allow physicians to manage the
massive data collected and help reduce errors caused by [...]